Specialties: Oncology
ClinicalInterests: Lymphoma
Experience: Visiting scholar in SUNY University at Stony Brook in 2003
Education:
2005.9 - 2010.6 Bachelor degree in Clinical Medicine,Medical College of Jinan University, Guangzhou, China
2010.9-2015.6 Master and PhD degree of hematology by Prof.LI Yangqiu, Medical College of Jinan University, Guangzhou, China
Professionalmemberships:
2015-2021 Member of CSCO translation team
Member of lymphoma Professional Committeeof Guangdong Women Doctors Association
Member of Guangdong Precision MedicineApplication Association,Lymphoma Society
Publications:
1 Chen C#, Liu S#, Jiang X#, Huang L#, Chen F,Wei X, Guo H, Shao Y, Li Y*, Li W*. Tumor mutation burden estimated bya 69-gene-panel is associated with overall survival in patients with diffuselarge B-cell lymphoma. Exp Hematol Oncol. 2021;10(1):20.
2 Chen F, Pang D, Guo H, Ou Q, Wu X, Jiang X, Wei X, Liu S, HuangL, Liang Z, Zhou D, Li W. Clinical outcomes of newly diagnosed primary CNSlymphoma treated with ibrutinib-based combination therapy: A real-worldexperience of off-label ibrutinib use. Cancer Med. 2020;9(22):8676-8684.
3 Chen F, Pang D, Guo H, Jiang X, Liu S, Huang L, Wei X, Liang Z,Wang X, Li W. Clinicopathological Characteristics and Mutational Profiling ofAdult T-Cell Lymphoblastic Lymphoma in a Chinese Population. Cancer Manag Res.2020 ;12:3003-3012.
4 Chen F, Guo H, Mao C, Jiang X, Liu S, Huang L, Wei X, Liang Z,Zhou D, Li W. Unusual Relapse of Primary Central Nervous System Lymphoma BothInside and Outside Central Nervous System in Patient with VentriculoperitonealShunt. World Neurosurg. 2019;127:625-628.
5 Mao C#, Chen F#, Li Y#, Jiang X, Liu S, Guo H,Huang L, Wei X, Liang Z, Li W*, Tang K*.Characteristics and Outcomes of Primary Central Nervous System Lymphoma: ARetrospective Study of 91 Cases in a Chinese Population. World Neurosurg. 2019;123:e15-e24.
6 Liao Z, Lv X, Liu S, He Z, Chen S, Wang L, Li W, Li Y. Differentaberrant expression pattern of immune checkpoint receptors in patients withPTCL and NK/T-CL. Asia Pac J Clin Oncol. 2018;14(5):e252-e258.
7 Huang L, Zhang F, Zeng J, Guo H, Liu S, Wei X, Chen F, Jiang X,Liang Z, Liu Y, Li W. ALK expression plays different roles in anaplasticlarge-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+patients in a Chinese population. Ann Hematol. 2018;97(1):149-159.
